 Sydney Morning Herald |
Anti-osteoporosis drugs bisphosphonates boost esophageal cancer risk
Food Consumer Taking anti-osteoporosis drugs known as oral bisphosphonates may double the risk of esophageal cancer, according to a new UK case-control study released in British Medical Journal. Dr. Jane Green and colleagues from the University of Oxford's Cancer … Health Buzz: Popular Osteoporosis Drugs Linked to Cancer Risk Osteoporosis Drugs Tied to Esophageal Cancer |